Skip to main content

The comparative hemodynamic effects of intravenous IQB-9302 and bupivacaine in anesthetized rats

Buy Article:

$43.00 plus tax (Refund Policy)


The new local anesthetic IQB-9302 is an amide derivative bearing a cyclopropyl group, with remarkable long duration of action and relative low toxicity. In trying to characterize further its safety profile, the current study compared the hemodynamic effects of different concentrations of bupivacaine and IQB-9302 with saline. Methods: 

Two groups of eight anesthetized Sprague–Dawley rats were given 0.1, 0.3, 1, 3, and 10 mg/kg of intravenous (i.v.) IQB-9302 or bupivacaine at 20-min intervals; control animals received saline only. Arterial blood pressure and heart rate were monitored during the following 20 min. Results: 

Both bupivacaine and IQB-9302 reduced heart rate: for bupivacaine, −73.8 beats per min (bpm) (SD: 103.8) and −132.5 bpm (SD: 140.7) at 1 and 3 mg/kg, respectively; for IQB-9302, the reduction amounted to −40.8 bpm (SD: 14.2) and −113.5 bpm (SD: 94.2) at 1 and 3 mg/kg, respectively (baseline range, 318.7–438.2 bpm). The two drugs also produced a comparable increase in the mean arterial blood pressure; bupivacaine increased it by 8.7 mmHg (SD: 6.6) and 12.6 mmHg (SD: 15.4) at 1 and 3 mg/kg, respectively, and IQB-9302, 18.7 mmHg (SD: 21.1) and 20.7 mmHg (SD: 20.5) at 1 and 3 mg/kg, respectively (baseline range, 47.4–134.1 mmHg). All rats treated with 10 mg/kg of either drug died after a drop in heart rate and mean arterial blood pressure. Conclusion: 

IQB-9302 had hemodynamic effects similar to those of bupivacaine in anesthetized rats. The clinical relevance of these effects warrants further investigation.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: IQB-9302; bupivacaine; hemodynamics; local anesthetics

Document Type: Research Article

Affiliations: 1: Anesthesiology, Hospital Universitario La Princesa, and 2: Clinical Pharmacology and

Publication date: 2004-05-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more